tiprankstipranks
Compass Therapeutics price target raised to $7 from $5 at Ladenburg
The Fly

Compass Therapeutics price target raised to $7 from $5 at Ladenburg

Ladenburg analyst Aydin Huseynov raised the firm’s price target on Compass Therapeutics (CMPX) to $7 from $5 and keeps a Buy rating on the shares post the Q3 report. The firm notes growing optimism around CTX-009.

Don't Miss Our Christmas Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App